Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
24.45B | 23.86B | 23.95B | 23.22B | 22.50B | 23.56B | Gross Profit |
8.43B | 7.29B | 9.27B | 10.02B | 9.53B | 9.29B | EBIT |
1.95B | 1.02B | 2.18B | 2.92B | 2.99B | 3.45B | EBITDA |
2.49B | 1.66B | 2.72B | 4.18B | 4.59B | 5.29B | Net Income Common Stockholders |
1.30B | 603.18M | 1.44B | 2.05B | 2.46B | 1.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.47B | 13.84B | 13.20B | 12.94B | 11.93B | 9.56B | Total Assets |
21.05B | 22.70B | 21.30B | 20.83B | 20.47B | 19.58B | Total Debt |
7.00M | 9.91M | 13.99M | 8.68M | 57.97M | 97.45M | Net Debt |
-11.96B | -13.32B | -12.69B | -12.40B | -11.37B | -9.46B | Total Liabilities |
7.23B | 8.48B | 6.56B | 6.09B | 6.43B | 6.76B | Stockholders Equity |
13.82B | 14.22B | 14.74B | 14.75B | 14.04B | 12.82B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.96B | 1.62B | 2.35B | 3.76B | 1.68B | Operating Cash Flow |
0.00 | 2.28B | 2.20B | 3.24B | 4.09B | 3.42B | Investing Cash Flow |
0.00 | -759.16M | -565.77M | -865.46M | -306.41M | -1.43B | Financing Cash Flow |
0.00 | -1.46B | -1.46B | -1.50B | -1.42B | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $22.01T | 19.51 | 14.32% | 0.53% | 9.56% | 26.52% | |
77 Outperform | $2.13T | 17.53 | 12.67% | 0.84% | 10.80% | 138.34% | |
76 Outperform | ¥623.17B | 28.60 | 13.71% | 1.22% | 6.70% | 89.77% | |
71 Outperform | ¥3.71T | 25.15 | 1.32% | 6.51% | -0.45% | ||
63 Neutral | ¥29.45B | 19.26 | 5.03% | 1.12% | 89.58% | ||
60 Neutral | $11.62B | 10.48 | -7.27% | 2.93% | 7.46% | -10.64% | |
46 Neutral | $1.91T | ― | -22.97% | ― | 10.38% | 38.09% |